Education:
2019 – 2025: Postdoctoral Fellow, National Institute on Alcohol Abuse and Alcoholism
(NIAAA), National Institutes of Health (NIH)
2014 – 2019: Ph.D. in Pharmaceutical Sciences, University of Maryland School of Pharmacy
2010 – 2014: Bachelors in Science (Biology), University of North Carolina – Chapel
Hill
Research/Teaching Interests:
The main goal of our laboratory is to bridge the gap between preclinical alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) research. We study mechanisms that underlie both diseases, contributing to both alcohol consumption and subsequent organ injury using biochemical, pharmacological, and behavioral models. Ultimately, we aim to identify novel targetable pathways controlling AUD and ALD initiation and progression that we can translate to the clinic for AUD and ALD patients.
Awards and Fellowships:
2024: NIAAA K99/R00 Pathway to Independence Award
2022, 2024: Fellows Award for Research Excellence, NIH
2017: Transform Tox Testing Challenge Stage 2 Winner (Tox21/EPA/NCATS)